Article info
Editorial
Drugs without benefits? Confronting the challenges of drug-induced interstitial lung disease
- Correspondence to Professor Joanna C Porter, Centre for Inflammation and Tissue Repair, UCL Respiratory, University College London Division of Medicine, WC1E 6JF London, UK; joanna.porter{at}ucl.ac.uk
Citation
Drugs without benefits? Confronting the challenges of drug-induced interstitial lung disease
Publication history
- Accepted July 22, 2021
- First published August 5, 2021.
Online issue publication
September 01, 2022
Article Versions
- Previous version (10 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.